BN 80933

Drug Profile

BN 80933

Alternative Names: BIM 80933; BN80933

Latest Information Update: 30 Nov 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Institut Henri Beaufour-Ipsen
  • Class Anti-ischaemics; Antiparkinsonians; Neuroprotectants; Pyrazines; Small molecules; Thiophenes
  • Mechanism of Action Free radical scavengers; Lipid peroxidation inhibitors; Nitric oxide synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cerebral ischaemia; Neurological disorders

Most Recent Events

  • 22 Oct 2003 A preclinical study has been added to the Neurological disorders pharmacodynamics section
  • 05 Jun 2003 Beaufour-Ipsen is now called Ipsen
  • 21 Dec 2001 BIM 80933 is available for licensing
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top